INVO Bioscience Total Current Liabilities

INVO Bioscience (INVO) currently reports a total current liabilities of $6.4B as of March 2026. That compares with $19B in the prior-year period — down 66.0% year over year. Use the charts on this page to explore INVO Bioscience's total current liabilities history and peer comparisons.

INVO Bioscience's total current liabilities decreased from $19B to $6.4B — a 66.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

INVO Bioscience reported $6.4B in total current liabilities as of March 2026. That compares with $19B in the prior-year period — down 66.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $6.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for INVO Bioscience, and consider following INVO for alerts when major investors trade the stock.

INVO Bioscience is classified in the Healthcare sector. On total current liabilities, it currently shows $6.4B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INVO with unrelated industries.